Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 17;13(3):968. doi: 10.3390/nu13030968

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Complete blood count monitored during the treatment period. (a) Hemoglobin, (b) erythrocyte count (c) hematocrit and (d) mean corpuscular volume (MCV) measured in blood samples on days 0, 3, and 7 and at study termination on day 15. Data are presented as mean ± SEM. No significant difference was observed between treatment groups (Ferplex^® versus FeSO₄) and doses. Neither was any significant difference detected between treatment groups at any time point. At termination there was no significant difference between treatment groups and control. Data were analyzed by means of a Kruskal-Wallis test followed by Dunnett’s multiple comparison test. N = 5–8.